Lola Boutin

Artiklar

Article: ONCOIMMUNOLOGY. 2025;14(1):2485535
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity
Boutin L; Liu M; Merville JD; Bedoya-Reina O; Wilhelm MT
Article: NEURO-ONCOLOGY. 2024;27(3):779-794
Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing
van Bree N; Oppelt A-S; Lindstroem S; Zhou L; Boutin L; Coyle B; Swartling FJ; Johnsen JI; Braeutigam L; Wilhelm M
Article: NEURO-ONCOLOGY. 2024;26(9):1685-1699
High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma
Zhou L; van Bree N; Boutin L; Ryu J; Moussaud S; Liu M; Otrocka M; Olsson M; Falk A; Wilhelm M
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2024;54(8):e2350773
Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents
Boutin L; Barjon C; Chauvet M; Lafrance L; Senechal E; Bourges D; Vigne E; Scotet E
Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(9):4637-4651
γ9δ2T cell diversity and the receptor interface with tumor cells.
Vyborova A; Beringer DX; Fasci D; Karaiskaki F; van Diest E; Kramer L; de Haas A; Sanders J; Janssen A; Straetemans T; Olive D; Leusen J; Boutin L; Nedellec S; Schwartz SL; Wester MJ; Lidke KA; Scotet E; Lidke DS; Heck AJ; Sebestyen Z; Kuball J